Detailed Study Notes on Metabolism, Lipid Transport, and Drug Interactions

Muscle cells require ATP for energy, especially during high demand activities.
Liver cells primarily make ATP as a chemical energy source for anabolic processes.
Differences in tissue function explain variations in energy metabolism.

Mitochondrial membrane houses important processes related to energy production.
Cytochrome c:
- Role in the electron transport chain (ETC).
- Acts as a mobile carrier moving electrons from Complex III to Complex IV.
- Essential for generating a proton gradient for oxidative phosphorylation.

A phospholipid found in heart tissue and heavily associated with mitochondria.
Contains four fatty acids and two phosphate groups, which is atypical for phospholipids.
Cardiolipin is crucial for mitochondrial function, and defects can lead to diseases associated with mitochondrial dysfunction rather than just heart muscle issues.
Interaction between cytochrome c and cardiolipin:
- Predominantly hydrophobic interactions.
- Possible electrostatic interactions given cardiolipin's polar phosphate groups.

Some antibiotics block the F0 subunit of ATP synthase, leading to decreased aerobic respiration.
Reduction of oxidative phosphorylation can cause increased lactate concentration due to reliance on anaerobic respiration.
Most antibiotics affect bacterial systems more than mammalian systems due to differences in ATP synthase structures.

Stage 1 Metabolism:
- Digestion of dietary fats primarily occurs in the small intestine, with emulsification aided by bile salts.
- Bile salts are steroids synthesized from cholesterol, combining hydrophobic and hydrophilic properties.
Transport of Fats:
- Triglycerides cannot directly enter the bloodstream and must be packaged into lipoproteins (like chylomicrons).
- Microns are formed to transport dietary fats to peripheral tissues.

Chylomicrons: Transport dietary fats from intestines to peripheral tissues.
Remnants: Cholesterol-rich versions of chylomicrons that contain leftover triglycerides and cholesterol.
Very Low-Density Lipoproteins (VLDLs):
- Transport fats produced by the liver, primarily triglycerides.
- Levels indicate liver fat synthesis.
Low-Density Lipoproteins (LDLs): Transport cholesterol from the liver to peripheral tissues, high levels indicate potential for cardiovascular issues.
High-Density Lipoproteins (HDLs): Responsible for clearing old cholesterol, high levels associated with better cardiovascular health.

Total cholesterol < 200 mg/dL is ideal.
LDL levels:
- Keep below < 100 mg/dL; risk increases if levels are higher.
- Recommended for high-risk patients to maintain even lower levels, potentially under 70 mg/dL.
HDL levels:
- Typically higher in women; levels < 40 mg/dL for men considered low.

Statins: Common first line for lowering cholesterol but can have drug-drug interactions due to metabolism through the P450 enzyme system.
Recent recommendations suggest a more personalized treatment approach considering family history, ethnicity, and coexisting conditions like diabetes.

Hydrolysis of Triglycerides: Breaks down into glycerol and free fatty acids (FFA) in the cytosol using lipases.
Glycerol can enter glycolysis after phosphorylation into glycerol-3-phosphate.
Beta-Oxidation of Fatty Acids: Takes place in mitochondria, producing acetyl-CoA, NADH, and FADH2 from fatty acids, which is crucial for energy production.
Each cycle requires the transfer of fatty acids onto Coenzyme A and utilizes carnitine to transport acyl-CoA across mitochondrial membranes.
Fatty acids cannot be converted into glucose, but glycerol can enter gluconeogenesis.